Cargando…

Down-Regulation of CYP3A4 by the K(Ca)1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid Models

The large-conductance Ca(2+)-activated K(+) channel, K(Ca)1.1, plays a pivotal role in cancer progression, metastasis, and the acquisition of chemoresistance. Previous studies indicated that the pharmacological inhibition of K(Ca)1.1 overcame resistance to doxorubicin (DOX) by down-regulating multid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohya, Susumu, Kajikuri, Junko, Kito, Hiroaki, Matsui, Miki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648085/ https://www.ncbi.nlm.nih.gov/pubmed/37958656 http://dx.doi.org/10.3390/ijms242115672

Ejemplares similares

K(Ca)1.1 K(+) Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model
por: Ohya, Susumu, et al.
Publicado: (2021)

Ca(2+)‐activated K(+) channel K(Ca)1.1 as a therapeutic target to overcome chemoresistance in three‐dimensional sarcoma spheroid models
por: Ohya, Susumu, et al.
Publicado: (2021)

Downregulation of IL-8 and IL-10 by the Activation of Ca(2+)-Activated K(+) Channel K(Ca)3.1 in THP-1-Derived M(2) Macrophages
por: Ohya, Susumu, et al.
Publicado: (2022)

Histone Deacetylases Enhance Ca(2+)-Activated K(+) Channel K(Ca)3.1 Expression in Murine Inflammatory CD4(+) T Cells
por: Matsui, Miki, et al.
Publicado: (2018)

Transcriptional Repression and Protein Degradation of the Ca(2+)-Activated K(+) Channel K(Ca)1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells
por: Khatun, Anowara, et al.
Publicado: (2018)

Transcriptional repression of human epidermal growth factor receptor 2 by ClC‐3 Cl(−)/H(+) transporter inhibition in human breast cancer cells
por: Fujimoto, Mayu, et al.
Publicado: (2018)

Down-Regulation of Ca(2+)-Activated K(+) Channel K(Ca)1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists
por: Khatun, Anowara, et al.
Publicado: (2016)

Possible Contribution of Inflammation-Associated Hypoxia to Increased K(2P)5.1 K(+) Channel Expression in CD4(+) T Cells of the Mouse Model for Inflammatory Bowel Disease
por: Endo, Kyoko, et al.
Publicado: (2019)

Role of K(+) and Ca(2+)-Permeable Channels in Osteoblast Functions
por: Kito, Hiroaki, et al.
Publicado: (2021)

Downregulation of the Ca(2+)‐activated K(+) channel K(C) (a)3.1 by histone deacetylase inhibition in human breast cancer cells
por: Ohya, Susumu, et al.
Publicado: (2016)

Pathophysiological significance of the two-pore domain K(+) channel K(2P)5.1 in splenic CD4(+)CD25(−) T cell subset from a chemically-induced murine inflammatory bowel disease model
por: Nakakura, Sawa, et al.
Publicado: (2015)

Detection of Small CYP11B1 Deletions and One Founder Chimeric CYP11B2/CYP11B1 Gene in 11β-Hydroxylase Deficiency
por: Xie, Hua, et al.
Publicado: (2022)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
por: Takeda, Yoshimichi, et al.
Publicado: (2023)

The combined activation of K(Ca)3.1 and inhibition of K(v)11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
por: Pillozzi, Serena, et al.
Publicado: (2018)

Activation of Cyp1a1 and Cyp1a2 Genes in Adult Mouse Hepatocytes in Primary Culture
por: Nemoto, Nobuo, et al.
Publicado: (1993)

Dopamine D(2)-Receptor Antagonists Down-Regulate CYP1A1/2 and CYP1B1 in the Rat Liver
por: Harkitis, P., et al.
Publicado: (2015)

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk
por: Bethke, Lara, et al.
Publicado: (2007)

A novel chimeric CYP11B2/CYP11B1 combined with a new p.L340P CYP11B1 mutation in a patient with 11OHD: case report
por: Duan, Lian, et al.
Publicado: (2018)

Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
por: Kaaijk, P., et al.
Publicado: (1996)

Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time
por: Baek, NamHuk, et al.
Publicado: (2016)

Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin
por: Cortini, Margherita, et al.
Publicado: (2023)

Ectopic localization of CYP11B1 and CYP11B2-expressing cells in the normal human adrenal gland
por: Duparc, Céline, et al.
Publicado: (2022)

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
por: Bessone, Federica, et al.
Publicado: (2021)

Castration Induces Down-Regulation of A-Type K(+) Channel in Rat Vas Deferens Smooth Muscle
por: Ohya, Susumu, et al.
Publicado: (2019)

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
por: Grayson, Korie A., et al.
Publicado: (2021)

SUN-711 Association of Single Nucleotide Polymorphisms of CYP11B2, CYP11B1 and CYP17A1 with Primary Aldosteronism in a Multi-Ethnic Malaysian Cohort
por: Azam, Afifah, et al.
Publicado: (2020)

Case Report: A combination of chimeric CYP11B2/CYP11B1 and a novel p.Val68Gly CYP11B1 variant causing 11β-Hydroxylase deficiency in a Chinese patient
por: Li, Jialin, et al.
Publicado: (2023)

Mapping the functional expression of auxiliary subunits of K(Ca)1.1 in glioblastoma
por: Feher, Adam, et al.
Publicado: (2022)

Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
por: Berrazouane, Sofiane, et al.
Publicado: (2019)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Ultrafine carbon particles down-regulate CYP1B1 expression in human monocytes
por: Eder, Christiane, et al.
Publicado: (2009)

Alteration in the Expression of Cytochrome P450s (CYP1A1, CYP2E1, and CYP3A11) in the Liver of Mouse Induced by Microcystin-LR
por: Zhang, Bangjun, et al.
Publicado: (2015)

Increased doxorubicin uptake and toxicity in multicellular tumour spheroids treated with DC electrical fields
por: Sauer, H, et al.
Publicado: (1999)

Genetic Analyses of the Chimeric CYP11B1/CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism
por: Lee, Ihn Suk, et al.
Publicado: (2010)

Exploration of KCNJ5 Somatic Mutation and CYP11B1/CYP11B2 Staining in Multiple Nodules in Primary Aldosteronism
por: Xie, Jing, et al.
Publicado: (2022)

OR08-03 Ectopic Localization Of CYP11B1 and CYP11B2-Expressing Cells In The Normal Human Adrenal Gland
por: Duparc, Céline, et al.
Publicado: (2023)

Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids
por: Stöhr, Daniela, et al.
Publicado: (2020)

Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
por: Hartung, Franziska, et al.
Publicado: (2016)

The A’-helix of CYP11A1 remodels mitochondrial cristae
por: Rosal, Karen G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rofrc6rp1fqd35bukepakg5h6r